We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
Cap. Flow
+$100M
Cap. Flow %
0.49%
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167

Sector Composition

Rank Sector Weight
1 Technology 9.45%
2 Financials 4.68%
3 Healthcare 4.07%
4 Consumer Discretionary 3.92%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRP icon
3201
Kimbell Royalty Partners
KRP
$1.5B
-32,088
Closed -$536K
LCNB icon
3202
LCNB Corp
LCNB
$281M
-36,150
Closed -$651K
LII icon
3203
Lennox International
LII
$14.5B
-1,066
Closed -$255K
LITE icon
3204
Lumentum
LITE
$72.5B
-6,765
Closed -$353K
LPG icon
3205
Dorian LPG
LPG
$1.91B
-21,621
Closed -$410K
LPX icon
3206
Louisiana-Pacific
LPX
$5.15B
-5,609
Closed -$332K
MGPI icon
3207
MGP Ingredients
MGPI
$381M
-5,116
Closed -$544K
MOH icon
3208
Molina Healthcare
MOH
$10.8B
-1,404
Closed -$464K
MTGP icon
3209
WisdomTree Mortgage Plus Bond Fund
MTGP
$74.2M
-11,328
Closed -$493K
MVST icon
3210
Microvast
MVST
$354M
-10,010
Closed -$15K
NAC icon
3211
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
-10,452
Closed -$116K
FEED
3212
ENvue Medical Inc
FEED
$3.79M
-7
Closed -$4K
NBTB icon
3213
NBT Bancorp
NBTB
$2.78B
-4,771
Closed -$207K
NKX icon
3214
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$664M
-13,721
Closed -$169K
NRK icon
3215
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$918M
-10,003
Closed -$103K
NYC
3216
American Strategic Investment Co
NYC
$24M
-6,969
Closed -$99K
OCTT icon
3217
AllianzIM U.S. Equity Buffer10 Oct ETF
OCTT
$56.1M
-7,552
Closed -$213K
OPP
3218
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
-11,339
Closed -$97K
PBF icon
3219
PBF Energy
PBF
$8.34B
-9,659
Closed -$394K
PDD icon
3220
Pinduoduo
PDD
$127B
-2,466
Closed -$201K
PHDG icon
3221
Invesco S&P 500 Downside Hedged ETF
PHDG
$64.7M
-23,535
Closed -$760K
IMVP
3222
Invesco India ETF
IMVP
$107M
-13,959
Closed -$297K
PKE icon
3223
Park Aerospace
PKE
$828M
-14,402
Closed -$193K
PPT
3224
Franklin Premier Income Trust
PPT
$330M
-11,580
Closed -$42K
PRPH
3225
DELISTED
ProPhase Labs
PRPH
-3,074
Closed -$296K

Similar funds

Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
  • Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
  • Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
  • Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.